Host-pathogen interactions in Lyme disease and their application in diagnostics

Leiden Repository

Host-pathogen interactions in Lyme disease and their application in diagnostics

Title: Host-pathogen interactions in Lyme disease and their application in diagnostics
Author: Burgel, Nathalie Daniëlle van
Publisher: Department of Medical Microbiology, Faculty of Medicine, Leiden University Medical Center (LUMC), Leiden University
Issue Date: 2013-05-29
Keywords: Lyme
Borrelia
Complement
Serology
Diagnostics
CXCL13
Abstract: B. burgdorferi has a wide variety of strategies to hide from the host immune system. Complement regulatory binding proteins have been described for almost all complement resistant B. burgdorferi sl, except for the complement resistant B. bavariensis, one of the species that is known to frequently cause Lyme neuroborreliosis. In chapter 2 it is attempted to identify CRASP-1 proteins in B. bavariensis, formerly known as B. garinii OspA serotype 4. Potential CRASP-1 proteins will be cloned and studied for their ability to interact with host derived fluid phase regulators of complement. The specific role of complement resistance in early effective infection and dissemination of B. burgdorferi sl has not been well investigated. Can complement resistance lead to a better and more effective infection and dissemination? In chapter 3 an in vivo experiment in which the infectivity and dissemination patterns of complement sensitive and complement resistant B. burgdorferi sl in a C3 deficient mouse model is described. After effective transmission from the tick to the host the next challenge in B. burgdorferi infection is rapid and accurate detection of the pathogen. Diagnostics of Lyme disease is often compromised due to specific pathogen properties combined with technical shortcomings of bacterial serology. Two indirect detection methods which can aid in diagnosing patients suffering from Lyme neuroborreliosis were studied. In chapter 4 the performance of the C6-peptide ELISA for detecting antibodies in CSF in Lyme neuroborreliosis patients is studied. While in chapter 5 levels of CXCL13 in several patient populations as a potential biomarker for the diagnosis of Lyme neuroborreliosis is studied. For both indirect markers of presence of B. burgdorferi the specificity in clinically resembling and neuroinfectious diseases is of key importance. Several other infectious and inflammatory diseases that have a clinical presentation that can resemble Lyme disease are included in the analysis. Diagnosing Lyme disease can be difficult in some populations, first because Lyme disease is a relatively rare infection, resembling a large spectrum of other autoimmune and inflammatory diseases. Clinicians could often consider testing for Lyme disease. It is also important to do this in specific preselected populations, because the positive predictive value of a test, but specifically indirect tests such as serology, in a random population, is low.In chapter 6 all patients that present with complaints of arthritis at the early arthritis clinic are tested for Lyme arthritis. The prevalence of B. burgdorferi seropositivity in this population is studied. Another aim is to identify clinical factors which should urge the doctor to test, or explicitely not test, for Lyme disease in a patient presenting with arthritis in Europe. In chapter 7 a case of an HIV positive patient presenting with a meningoencephalitis caused by B. burgdorferi is described. The literature on HIV and Lyme neuroborreliosis co-infections is also reviewed.
Description: Promotor: A.C.M. Kroes, Co-Promotor: A.P. van Dam
With Summary in Dutch
Faculty: LUMC
Citation: Burgel, N.D. van, 2013, Doctoral Thesis, Leiden University
ISBN: 9789461693815
Handle: http://hdl.handle.net/1887/21004
 

Files in this item

Description Size View
application/pdf Full Text 10.49Mb View/Open
application/pdf Cover 315.4Kb View/Open
application/pdf Title Pages_Contents 138.4Kb View/Open
application/pdf Chapter 1 3.271Mb View/Open
application/pdf Chapter 2 3.212Mb View/Open Full text at publisher site
application/pdf Chapter 3 1.019Mb View/Open Full text at publisher site
application/pdf Chapter 4 408.4Kb View/Open Full text at publisher site
application/pdf Chapter 5 449.4Kb View/Open Full text at publisher site
application/pdf Chapter 6 962.4Kb View/Open
application/pdf Chapter 7 794.4Kb View/Open Full text at publisher site
application/pdf Chapter 8 624.4Kb View/Open
application/pdf References_Abbreviations 634.6Kb View/Open
application/pdf Summary in Dutch 195.7Kb View/Open
application/pdf Publications_Curriculum Vitae_Acknowledgements 199.1Kb View/Open
application/pdf Propositions 112.1Kb View/Open

This item appears in the following Collection(s)